Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis

Vázquez Bourgon, Javier; Ortiz García de la Foz, Víctor; Suarez Pereira, Irene; Iruzubieta, Paula; Arias Loste, María Teresa; Setién Suero, María Esther; Ayesa Arriola, Rosa; Gómez Revuelta, Marcos; Crespo García, Javier; Crespo Facorro, Benedicto

doi:10.1016/j.dib.2019.104415

Ver/Abrir

DataRegardingEffectC ... (188.3Kb)

Identificadores

URI: http://hdl.handle.net/10902/21896

DOI: 10.1016/j.dib.2019.104415

ISSN: 2352-3409

Fecha

2019-12

Derechos

Attribution-NonCommercial-NoDerivatives 4.0 International

Publicado en

Data in brief 27 (2019) 104415

Editorial

Elsevier BV

Enlace a la publicación

https://doi.org/10.1016/j.dib.2019.104415

Palabras clave

Cannabis

Psychosis

Liver

Liver steatosis

NAFLD

Resumen/Abstract

The presented article describes data from secondary analyses, related to the research article entitled ?Cannabis consumption and Non-Alcoholic Fatty Liver Disease. A three years longitudinal study in first episode non-affective psychosis patients? [1]. We present detailed data regarding the socio-demographic and baseline clinical characteristics of a sample of 390 drug-naïve patients with a first episode of non-affective psychosis, and the differences between cannabis users and non-users in those characteristics. Tables also show the results from cross-sectional and longitudinal statistical analyses exploring the relation between cannabis consumption and liver function, after excluding those patients with hazardous alcohol drinking.

Colecciones a las que pertenece

D22 Artículos [1093]

Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International